How to Buy Conmed Stock
Conmed Corp
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide.
Conmed stock last closed at $67.22, up 2.19% from the previous day, and has decreased 46.59% in one year. It has underperformed other stocks in the Medical Devices industry by 0.31 percentage points. Conmed stock is currently +10.11% from its 52-week low of $61.05, and -51.46% from its 52-week high of $138.47.
At the moment, there are 30.8M CNMD shares outstanding. The market value of CNMD is $2.07B. In the last 24 hours, 584,736 CNMD shares were traded.
How to Buy Conmed Stock
Not sure how to invest in Conmed stock? Here's how.
- Decide where to buy Conmed stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Conmed stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Select your method of payment and add your information.
- Analyze Conmed stock: The Conmed ticker symbol is CNMD. Is Conmed stock a good investment? Should you buy shares of CNMD? How do CNMD's underlying business fundamentals look? Do top analysts think Conmed is a good buy? Why has CNMD's stock price moved recently? (Hint: Our stock market research website can help you evaluate if CNMD is a good stock to buy).
- Execute your CNMD buy order: Decide if you will purchase CNMD shares at the current market price or use a limit order to purchase CNMD stock at a specific price.
- Get updates on your investment in CNMD: Create a watchlist to keep track of your investment in Conmed shares.
Step 1: Decide where to buy Conmed stock
You need an online brokerage account in order to access the NYSE market and buy CNMD shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Tech to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal information so you can buy CNMD stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new trading account.
- Send your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have filled out your info on one of the best stock apps, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your new investment account.
Step 4: Analyze Conmed stock
After you have selected the best place to buy Conmed stock, it's very important to research their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Overview of key CNMD info
Conmed Overview
WallStreetZen was built to help everyday investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on CNMD's stock page.
Is CNMD stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CNMD's fair value.
Using relative valuations measures:
- CNMD may be undervalued based on its P/E ratio of 24.99x, relative to Medical Devices industry P/E ratio of 27.9x
- CNMD may be undervalued based on its P/B ratio of 2.42x, relative to Medical Devices industry P/B ratio of 3.73x
- CNMD could be undervalued based on its PEG ratio of 0.55x
You can do additional valuation research on CNMD's stock here.
Is CNMD a healthy company?
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the CNMD balance sheet.
- CNMD profit margin has gone up from -8.5% to 6.5% in the past year.
Negative Financial Indicators:
- Total CNMD debt is higher than 5 years ago, relative to shareholder equity.
- CNMD's operating cash flow of $158.32M allows it to safely service it's debt of $990.80M.
- There are more long-term liabilities than short-term assets on the CNMD balance sheet.
- CNMD has a relatively high debt to equity ratio of 1.7.
- CNMD earnings of $142.92M is not enough to cover its interest payments.
Do Wall Street analysts think it's a good time to buy CNMD stock
Out of 5 Wall Street analysts who give recommendations on CNMD, the consensus analyst rating on Conmed is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Conmed stock forecast page.
CNMD Technical Indicators
CNMD Earnings
Last year, CNMD earnings were $82.35M. Over the past 5 year, CNMD's earnings have grown by 19.37% per year. This was faster than the Medical Devices industry average of 8.5%.
Last year, CNMD revenue was $1.26B. In the past five year, CNMD's revenue has gone up by 7.57% per year. This was slower than the Medical Devices industry average of 13.19%.
Learn more about CNMD's earnings and revenue performance here.
Who is buying/selling CNMD?
Over the past 12 months, executives and large shareholders at CNMD have bought more shares than they have sold.
Heather L. Cohen, EVP Chief HR Legal Officer of CNMD, was the latest CNMD insider to buy. They bought $17,270.16 worth of CNMD shares on Mar 28, 2024.
Dig into more about who owns CNMD stock here.
Can I get consistent income from CNMD stock?
Conmed pays a dividend of 1.19%, compared to the Medical Devices industry's average dividend yield of 1.57%. If you owned $1,000 of CNMD stock, you would have received $11.90 in the past year.
Conmed dividend payments have not consistently grown over the past decade but have remained stable.
Find more analysis about Conmed dividend yield and history here.
CNMD Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your CNMD buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact price limit, place a limit order.
Hit the Open Trade button and eToro will place your order.
If you require more info about buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your investment in CNMD
Now that you own some CNMD stock, you'll want to keep up with your new stock purchase.
Start a watchlist to get notified of the latest news about your CNMD stock.
CNMD Feed
How to Buy Stock in Conmed
To reiterate, here are the 6 steps for buying Conmed stock:
- Decide where to buy Conmed stock
- Create your brokerage account
- Deposit money your investment account
- Analyze Conmed stock
- Execute your CNMD buy order
- Get updates on your investment in CNMD
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get updates on your investment in Conmed, create a watchlist on WallStreetZen today.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.